Clovis: Market Valuation Is Still Far From Intrinsic Value [Seeking Alpha]
Clovis Oncology, Inc. (CLVS)
Last clovis oncology, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-irhome
Company Research
Source: Seeking Alpha
Clovis: Market Valuation Is Still Far From Intrinsic Value Summary Clovis is undergoing a strong comeback this month due to powerful fundamental developments. The company substantially reduced its high cash burn rate this quarter. The lead molecule (Rubraca) also generated robust data for the castration-resistant prostate cancer with an associated BRCA1/2 mutation. Clovis is on track to file a supplemental new drug application for Rubraca in prostate cancer by year-end. Meanwhile, Rubraca is poised to advance into the first-line maintenance for ovarian cancer. Don't be afraid of buying on a war scare. - Phillip Fisher One of the most opportunistic time to invest in a stock is when it's "beaten down but not out." When I say "not out," I mean that despite all the market negativity, the company is still undergoing strong fundamental advancement. I believe that when you invest in a company at that point in its life cycle, nearly all the risks are deleveraged. Warren Buffett's teacher (Ben
Show less
Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLVS alerts
High impacting Clovis Oncology, Inc. news events
Weekly update
A roundup of the hottest topics